Please use this identifier to cite or link to this item:
|Title:||Pathophysiology of diabetic nephropathy.|
|Authors:||Cooper, Mark E;Gilbert, Richard E;Epstein, M|
|Affiliation:||Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Heidelberg, Victoria, Australia.|
|Citation:||Metabolism: Clinical and Experimental; 47(12 Suppl 1): 3-6|
|Abstract:||Diabetic nephropathy (DN) is now the commonest cause of end-stage renal failure in the Western world. Recent studies examining the pathogenesis of diabetic complications have focused on the complex interaction between genetic and hemodynamic mechanisms in addition to metabolic factors such as advanced glycation, protein kinase C (PKC) activation, and polyol production. The importance of the various components, particularly with regard to the progression of DN, is currently being explored with the assistance of targeted drug intervention studies.|
|Internal ID Number:||9867062|
Glycosylation End Products, Advanced.metabolism
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.